<DOC>
	<DOCNO>NCT02352584</DOCNO>
	<brief_summary>A Multicenter , Randomized , Double-blind , Active-controlled , Parallel Phase III</brief_summary>
	<brief_title>A Multicenter , Double-blind , Parallel Phase III Study</brief_title>
	<detailed_description>A Multicenter , Randomized , Double-blind , Active-controlled , Parallel Phase III Study Investigate Efficacy ( Immunogenicity ) Safety GC3110A ( Quadrivalent Influenza Vaccine ) After Intramuscular Administration Healthy Subjects</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Criteria : Given write informed consent Healthy Korean adult ( age : 19 ) Korean adult agree 21 day follow vaccination good compliance study procedure Those able comply requirement study Inability written/verbal communication Subjects participate interventional study within 30 day Alcohol drug abuse within 6 month Who get treatment psychotropic drug narcotic analgesic drug within 6 month enrollment Disorders immune function History GuillainBarré syndrome Disease/medications likely cause severe bleed Active infection experience fever ( &gt; 38.0 ℃ ) within 72 hour follow vaccination Oral temperature &gt; 38.0 ℃ vaccination day Erythema , tattoo , injury shoulder ( vaccination site ) Hypersensitivity egg , chicken , vaccine component , Neomycin , Gentamicin Influenza vaccination within 6months Any vaccination within 30 day Concomitant medications/therapy immunosuppressant immune modify drug , systemic corticosteroid , immunoglobulin , blood blood derive product , anticancer chemotherapy radiation therapy within3 month Pregnant breastfeed woman Clinically significant underlying disease medical history investigator 's discretion</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>QIV</keyword>
	<keyword>Quadrivalent Influenza Vaccine</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Vaccination</keyword>
</DOC>